GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ondine Biomedical Inc (LSE:OBI) » Definitions » 3-Year EPS without NRI Growth Rate

Ondine Biomedical (LSE:OBI) 3-Year EPS without NRI Growth Rate : -10.10% (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Ondine Biomedical 3-Year EPS without NRI Growth Rate?

Ondine Biomedical's EPS without NRI for the six months ended in Jun. 2023 was £-0.02.

During the past 3 years, the average EPS without NRI Growth Rate was -10.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was -27.80% per year. During the past 10 years, the average EPS without NRI Growth Rate was 9.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Ondine Biomedical was 53.20% per year. The lowest was -157.10% per year. And the median was -10.10% per year.


Competitive Comparison of Ondine Biomedical's 3-Year EPS without NRI Growth Rate

For the Biotechnology subindustry, Ondine Biomedical's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ondine Biomedical's 3-Year EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ondine Biomedical's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Ondine Biomedical's 3-Year EPS without NRI Growth Rate falls into.



Ondine Biomedical 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Ondine Biomedical  (LSE:OBI) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Ondine Biomedical 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Ondine Biomedical's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Ondine Biomedical (LSE:OBI) Business Description

Industry
Traded in Other Exchanges
Address
1100 Melville Street, Suite 888, Vancouver, BC, CAN, V6E4A6
Ondine Biomedical Inc is a life sciences company, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. The company has created a platform technology called antimicrobial photodynamic disinfection, or photodisinfection, to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings. Canada is the major revenue generator for the group. The company has one reportable operating segment that is antimicrobial photodynamic therapy (aPDT) products.

Ondine Biomedical (LSE:OBI) Headlines

No Headlines